Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127551411 | 12755141 | 1 | I | 20160608 | 20160907 | 20160916 | 20160916 | EXP | CN-PFIZER INC-2016433568 | PFIZER | 62.00 | YR | M | Y | 70.00000 | KG | 20160916 | OT | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127551411 | 12755141 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY | 80 | MG | Y | N11250 | 20702 | 20 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127551411 | 12755141 | 1 | Arteriosclerosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127551411 | 12755141 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127551411 | 12755141 | Blood creatine phosphokinase increased | |
127551411 | 12755141 | Blood lactate dehydrogenase increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127551411 | 12755141 | 1 | 20160604 | 20160607 | 0 |